Cabozantinib Combined With Atezolizumab for Advanced RCC Cabozantinib Combined With Atezolizumab for Advanced RCC
This novel therapeutic combination shows encouraging results in patients with advanced renal cell carcinoma.Journal of Clinical Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 1, 2022 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
Mesothelioma Clinical Trial Studies Keytruda, Lenvatinib Combination
The objective response rate of the Keytruda/lenvatinib combination was an impressive 58%.
In 2020, the U.S. Food and Drug Administration approved the use of Keytruda for certain metastatic tumors, including certain cases of mesothelioma, but the search for an effective combination continues.
Lenvatinib has shown it can block tumor growth by targeting specific proteins Keytruda can’t reach. It has been effective with only select cancers and is known as precision medicine.
The drug, which is already FDA approved, has been used successfully with Keytruda for the treatment of endometrial cancer. Lenvatinib is prescr...
Source: Asbestos and Mesothelioma News - August 17, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Clinical Trials/Research/Emerging Treatments Pleural Source Type: news
Camp Lejeune Veterans Win Justice
On Wednesday, Aug. 10, President Joe Biden signed the comprehensive Honoring Our PACT Act of 2022 into law, allowing military veterans and families harmed by contaminated water at Marine Corps Base Camp Lejeune to file lawsuits against the federal government.
The Camp Lejeune Justice Act of 2022, which focuses on four decades of water contamination, is just one part of the much broader PACT Act, which expands access to health care and disability benefits for veterans harmed by toxic exposures around the world.
Biden lauded the bipartisan support for the PACT Act at the signing.
“There are a lot of issues we can...
Source: Asbestos and Mesothelioma News - August 10, 2022 Category: Environmental Health Authors: Chris Elkins Tags: Veterans Source Type: news
Targeted Therapy for Kidney Cancer Linked to Higher Cardiac Risk Targeted Therapy for Kidney Cancer Linked to Higher Cardiac Risk
Patients on targeted therapy were more likely to develop conditions such as heart attacks and stroke than were those who took cytokine therapy.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 3, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
The Latest Breakthroughs That Could Help Bladder Cancer Patients
Toward the end of the 19th century, a New York City surgeon named Dr. William Coley purposely injected one of his patients with streptococcal bacteria. Coley wasn’t crazy. He hoped the bacterial infection would stimulate an immune response that would slow the spread of his patient’s cancer, which was inoperable. The experiment worked; the patient’s tumor shrank.
For the next 40 years, Coley and his research collaborators would test similar remedies on more than 1,000 cancer patients. They had failures but also many successes, especially among people with bone or soft-tissue cancers. Today, Coley is someti...
Source: TIME: Health - July 27, 2022 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Disease freelance healthscienceclimate Source Type: news
Telix and BAMF use Illuccix for total-body prostate PET
Telix and BAMF Health are reporting the first use for prostate cancer imagin...Read more on AuntMinnie.comRelated Reading:
Telix announces new CEO and dose of final patient in ZIRCON study
Telix, Invicro further AI partnership
Telix gets pass-through status for Illuccix
Monrol to supply Telix with Lu-177 for renal cancer trial
Telix touts rollout of Illuccix PSMA-PET radiotracer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 27, 2022 Category: Radiology Source Type: news
Ringertz: Nobel prize for PET may lie on the horizon
VIENNA - A Nobel prize for PET imaging could well be on the cards in the year...Read more on AuntMinnie.comRelated Reading:
ECR: PET/MRI shows promise diagnosing breast cancer
SPECT/CT proves value over CT diagnosing renal cancer
PSMA-PET/CT comparable to MRI for detecting prostate cancer
Whole-body PET/CT for a child: 5 minutes, no sedation
PET/CT improves survival in lung cancer patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 19, 2022 Category: Radiology Source Type: news
Analysis Shows No Benefit for Cytoreductive Nephrectomy Analysis Shows No Benefit for Cytoreductive Nephrectomy
For patients with metastatic clear cell renal cell carcinoma, removing the kidney and its primary tumor is not associated with improved overall survival, a new analysis concludes.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 19, 2022 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Kluger appointed Cushing Professor of Internal Medicine and Dermatology
Harriet Kluger is an internationally renowned expert in the study and treatment of melanoma and renal cell carcinoma. (Source: Yale Science and Health News)
Source: Yale Science and Health News - July 18, 2022 Category: Universities & Medical Training Source Type: news
Telix announces new CEO and dose of final patient in ZIRCON study
Telix Americas has announced its new CEO, Kevin Richardson, and that it ha...Read more on AuntMinnie.comRelated Reading:
Telix, Invicro further AI partnership
Telix gets pass-through status for Illuccix
Monrol to supply Telix with Lu-177 for renal cancer trial
Telix touts rollout of Illuccix PSMA-PET radiotracer
Shine and Telix ink Lu-177 supply deal (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 11, 2022 Category: Radiology Source Type: news
SPECT/CT proves value over CT diagnosing renal cancer
SPECT/CT imaging appears more accurate than standard contrast-enhanced CT exam...Read more on AuntMinnie.comRelated Reading:
Tc-99m SPECT/CT imaging detects COVID-19
SPECT/CT augmented reality may help visualize metastatic melanoma
SNMMI offers letter to contest SPECT/CT denials
Follow-up SPECT/CT scan tracks radionuclide dose
SPECT/CT can solve renal cell carcinoma diagnosis conundrum (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 6, 2022 Category: Radiology Source Type: news
Immunotherapy Combos Up Survival in Renal Cell Carcinoma Immunotherapy Combos Up Survival in Renal Cell Carcinoma
In the absence of head-to-head trials, the findings help validate the applicability of phase 3 results to routine care. The study was published as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 1, 2022 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Warning: low survival rate in the UK as children are being diagnosed with cancer too late
CHILDHOOD cancers are being diagnosed too late in the UK leading to worse survival rates than comparable countries, experts have warned. Around 85 youngsters are diagnosed with Wilms' tumour - the most common children's kidney cancer - every year, most under the age of five. (Source: Daily Express - Health)
Source: Daily Express - Health - June 29, 2022 Category: Consumer Health News Source Type: news
New approach to treatment of deadly kidney cancer
Researchers at Karolinska Institutet in Sweden have linked resistance to treatment for a deadly form of kidney cancer to low mitochondrial content in the cell. When the researchers increased the mitochondrial content with an inhibitor, the cancer cells responded to the treatment. Their findings, which are published in Nature Metabolism, offer hope for more targeted cancer drugs. (Source: World Pharma News)
Source: World Pharma News - June 27, 2022 Category: Pharmaceuticals Tags: Featured Events Source Type: news
Father-of-one, 62, told he had just FOUR DAYS to live after doctors find kidney cancer
Richard Bernstein, 62, who lives in Montvale, went to doctors about the pain five years ago - but was discharged when no fracture was found. He was diagnosed with kidney cancer in March 2022. (Source: the Mail online | Health)
Source: the Mail online | Health - June 15, 2022 Category: Consumer Health News Source Type: news
